{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Amino acids", "Liquid chromatography", "Metabolomics", "Plasma", "Vitiligo"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34562159", "DateCompleted": {"Year": "2022", "Month": "01", "Day": "18"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "25"}], "Language": ["eng"], "ELocationID": ["92", "10.1007/s11306-021-01843-x"], "Journal": {"ISSN": "1573-3890", "JournalIssue": {"Volume": "17", "Issue": "10", "PubDate": {"Year": "2021", "Month": "Sep", "Day": "25"}}, "Title": "Metabolomics : Official journal of the Metabolomic Society", "ISOAbbreviation": "Metabolomics"}, "ArticleTitle": "Metabolomic signature of amino acids in plasma of patients with non-segmental Vitiligo.", "Pagination": {"StartPage": "92", "MedlinePgn": "92"}, "Abstract": {"AbstractText": ["Vitiligo pathogenesis is complicated, and several possibilities were suggested. However, it is well-known that the metabolism of pigments plays a significant role in the pathogenicity of the disease.", "We explored the role of amino acids in vitiligo using targeted metabolomics.", "The amino acid profile was studied in plasma using liquid chromatography. First, 22 amino acids were derivatized and precisely determined. Next, the concentrations of the amino acids and the molar ratios were calculated in 31 patients and 34 healthy individuals.", "The differential concentrations of amino acids were analyzed and eight amino acids, i.e., cysteine, arginine, lysine, ornithine, proline, glutamic acid, histidine, and glycine were observed differentially. The ratios of cysteine, glutamic acid, and proline increased significantly in Vitiligo patients, whereas arginine, lysine, ornithine, glycine, and histidine decreased significantly compared to healthy individuals. Considering the percentage of skin area, we also showed that glutamic acid significantly has a higher amount in patients with less than 25% involvement compared to others. Finally, cysteine and lysine are considered promising candidates for diagnosing and developing the disorder with high accuracy (0.96).", "The findings are consistent with the previously illustrated mechanism of Vitiligo, such as production deficiency in melanin and an increase in immune activity and oxidative stress. Furthermore, new evidence was provided by using amino acids profile toward the pathogenicity of the disorder."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran."}], "LastName": "Marzabani", "ForeName": "Rezvan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran. h_rezadoost@sbu.ac.ir."}], "LastName": "Rezadoost", "ForeName": "Hassan", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Applied Mathematics, Faculty of Mathematical Sciences, Tarbiat Modares University, Tehran, Iran."}], "LastName": "Choopanian", "ForeName": "Peyman", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Kolahdooz", "ForeName": "Sima", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran."}], "LastName": "Mozafari", "ForeName": "Nikoo", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290, Helsinki, Finland."}], "LastName": "Mirzaie", "ForeName": "Mehdi", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Karimi", "ForeName": "Mehrdad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolomics Unit, Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, 00290, Helsinki, Finland. anni.nieminen@helsinki.fi."}], "LastName": "Nieminen", "ForeName": "Anni I", "Initials": "AI"}, {"Identifier": ["0000-0002-6991-8587"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, 00290, Helsinki, Finland. mohieddin.jafari@helsinki.fi."}], "LastName": "Jafari", "ForeName": "Mohieddin", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Metabolomics", "NlmUniqueID": "101274889", "ISSNLinking": "1573-3882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Glutamates"}, {"RegistryNumber": "4QD397987E", "NameOfSubstance": "Histidine"}, {"RegistryNumber": "94ZLA3W45F", "NameOfSubstance": "Arginine"}, {"RegistryNumber": "9DLQ4CIU6V", "NameOfSubstance": "Proline"}, {"RegistryNumber": "E524N2IXA3", "NameOfSubstance": "Ornithine"}, {"RegistryNumber": "K3Z4F929H6", "NameOfSubstance": "Lysine"}, {"RegistryNumber": "K848JZ4886", "NameOfSubstance": "Cysteine"}, {"RegistryNumber": "TE7660XO1C", "NameOfSubstance": "Glycine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Amino Acids"}, {"QualifierName": [], "DescriptorName": "Arginine"}, {"QualifierName": [], "DescriptorName": "Cysteine"}, {"QualifierName": [], "DescriptorName": "Glutamates"}, {"QualifierName": [], "DescriptorName": "Glycine"}, {"QualifierName": [], "DescriptorName": "Histidine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Lysine"}, {"QualifierName": [], "DescriptorName": "Metabolomics"}, {"QualifierName": [], "DescriptorName": "Ornithine"}, {"QualifierName": [], "DescriptorName": "Proline"}, {"QualifierName": [], "DescriptorName": "Vitiligo"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abumrad, N., A. Barbul (2004). The use of arginine in clinical practice. Metabolic and therapeutic aspects of amino acids in clinical nutrition, 595\u2013611"}, {"Citation": "Agarwal S, Mendiratta V, Chander R, Jain A, Yadav P. Study of serum levels of Vitamin B12, folic acid, and homocysteine in vitiligo. Pigment International. 2015;2:76. doi: 10.4103/2349-5847.172777.", "ArticleIdList": ["10.4103/2349-5847.172777"]}, {"Citation": "Akoglu G, Neselioglu S, Karaismailoglu E, Aktas A, Erel O. Plasma thiol levels are associated with disease severity in nonsegmental vitiligo. Indian Journal of Dermatology. 2018;63:323. doi: 10.4103/ijd.IJD_586_17.", "ArticleIdList": ["10.4103/ijd.IJD_586_17", "PMC6052756", "30078877"]}, {"Citation": "Amiel JM, Mathew SJ. Glutamate and anxiety disorders. Current Psychiatry Reports. 2007;9:278\u2013283. doi: 10.1007/s11920-007-0033-7.", "ArticleIdList": ["10.1007/s11920-007-0033-7", "17880858"]}, {"Citation": "Armstrong, A. (2011). Advances in Malignant Melanoma: Clinical and Research Perspectives, BoD\u2013Books on Demand."}, {"Citation": "Bansal V, Ochoa JB. Arginine availability, arginase, and the immune response. Current Opinion in Clinical Nutrition & Metabolic Care. 2003;6:223\u2013228. doi: 10.1097/00075197-200303000-00012.", "ArticleIdList": ["10.1097/00075197-200303000-00012", "12589193"]}, {"Citation": "Bergink V, van Megen HJGM, Westenberg HGM. Glutamate and anxiety. European Neuropsychopharmacology. 2004;14:175\u2013183. doi: 10.1016/S0924-977X(03)00100-7.", "ArticleIdList": ["10.1016/S0924-977X(03)00100-7", "15056476"]}, {"Citation": "Binder MD, Hirokawa N, Windhorst U. Encyclopedia of neuroscience. Springer; 2009."}, {"Citation": "Coloff JL, et al. Differential glutamate metabolism in proliferating and quiescent mammary epithelial cells. Cell Metabolism. 2016;23:867\u2013880. doi: 10.1016/j.cmet.2016.03.016.", "ArticleIdList": ["10.1016/j.cmet.2016.03.016", "27133130"]}, {"Citation": "Cortese BM, Phan KL. The role of glutamate in anxiety and related disorders. CNS Spectrums. 2005;10:820\u2013830. doi: 10.1017/s1092852900010427.", "ArticleIdList": ["10.1017/s1092852900010427", "16400245"]}, {"Citation": "De Fabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. Journal of Experimental Medicine. 1983;158:84\u201398. doi: 10.1084/jem.158.1.84.", "ArticleIdList": ["10.1084/jem.158.1.84", "PMC2187071", "6223114"]}, {"Citation": "De Fabo EC, Webber LJ, Ulman EA, Broemeling LD. Dietary L-histidine regulates murine skin levels of trans-urocanic acid, an immune-regulating photoreceptor, with an unanticipated modulation: Potential relevance to skin cancer. The Journal of Nutrition. 1997;127:2158\u20132164. doi: 10.1093/jn/127.11.2158.", "ArticleIdList": ["10.1093/jn/127.11.2158", "9349842"]}, {"Citation": "Ding X, Du J, Zhang J. The Epidemiology and Treatment of Vitiligo: A Chinese Perspective. Pigmentary Disorders. 2014;1(2376\u20130427):1000148."}, {"Citation": "Ezzedine K, et al. Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell & Melanoma Research. 2012;25:E1\u2013E13. doi: 10.1111/j.1755-148X.2012.00997.x.", "ArticleIdList": ["10.1111/j.1755-148X.2012.00997.x", "PMC3511780", "22417114"]}, {"Citation": "Fekkes, D. (2012). Automated analysis of primary amino acids in plasma by high-performance liquid chromatography Amino Acid Analysis.(pp183\u2013200). Springer.", "ArticleIdList": ["22125146"]}, {"Citation": "Flynn N, Meininger C, Haynes T, Wu G. The metabolic basis of arginine nutrition and pharmacotherapy. Biomedicine & Pharmacotherapy. 2002;56:427\u2013438. doi: 10.1016/S0753-3322(02)00273-1.", "ArticleIdList": ["10.1016/S0753-3322(02)00273-1", "12481979"]}, {"Citation": "Gianfaldoni S, et al. Unconventional treatments for Vitiligo: Are they (Un) satisfactory? Open Access Macedonian Journal of Medical Sciences. 2018;6:170. doi: 10.3889/oamjms.2018.038.", "ArticleIdList": ["10.3889/oamjms.2018.038", "PMC5816295", "29484020"]}, {"Citation": "Gibbs NK, Tye J, Norval M. Recent advances in urocanic acid photochemistry, photobiology and photoimmunology. Photochemical & Photobiological Sciences. 2008;7:655\u2013667. doi: 10.1039/b717398a.", "ArticleIdList": ["10.1039/b717398a", "18528548"]}, {"Citation": "Grimes P, Miller M. Vitiligo: Patient stories, self-esteem, and the psychological burden of disease. International Journal of Women's Dermatology. 2018;4:32\u201337. doi: 10.1016/j.ijwd.2017.11.005.", "ArticleIdList": ["10.1016/j.ijwd.2017.11.005", "PMC5986114", "29872674"]}, {"Citation": "Hafez M, Sharaf L. The genetics of vitiligo. Acta Dermato-Venereologica. 1983;63:249\u2013251.", "ArticleIdList": ["6192645"]}, {"Citation": "Hamidizadeh N, Ranjbar S, Ghanizadeh A, Parvizi MM, Jafari P, Handjani F. Evaluating prevalence of depression, anxiety and hopelessness in patients with Vitiligo on an Iranian population. Health and Quality of Life Outcomes. 2020;18:20. doi: 10.1186/s12955-020-1278-7.", "ArticleIdList": ["10.1186/s12955-020-1278-7", "PMC6998062", "32013982"]}, {"Citation": "Hamza AM, Farid CI, El-sayed ET, Kadeeb HA. Assessment of serum homocysteine level in patients with nonsegmental vitiligo. Egyptian Journal of Dermatology and Venerology. 2015;35:59. doi: 10.4103/1110-6530.178461.", "ArticleIdList": ["10.4103/1110-6530.178461"]}, {"Citation": "Haug K, et al. MetaboLights: A resource evolving in response to the needs of its scientific community. Nucleic Acids Research. 2020;48:D440\u2013d444. doi: 10.1093/nar/gkz1019.", "ArticleIdList": ["10.1093/nar/gkz1019", "PMC7145518", "31691833"]}, {"Citation": "Henning SW, et al. The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data. PLoS ONE. 2020;15:e0227909. doi: 10.1371/journal.pone.0227909.", "ArticleIdList": ["10.1371/journal.pone.0227909", "PMC6984686", "31986193"]}, {"Citation": "Ito S, Wakamatsu K, Ozeki H. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment Cell Research. 2000;13:103\u2013109. doi: 10.1034/j.1600-0749.13.s8.19.x.", "ArticleIdList": ["10.1034/j.1600-0749.13.s8.19.x", "11041366"]}, {"Citation": "Jakku R, Thappatla V, Kola T, Kadarla RK. VITILIGO-An Overview. Asian Journal of Pharmaceutical Research and Development. 2019;7:124\u2013132."}, {"Citation": "Klemetti P, et al. Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy (APECED) Clinical & Experimental Immunology: Endocrine Disease. 2000;119:419\u2013425. doi: 10.1046/j.1365-2249.2000.01167.x.", "ArticleIdList": ["10.1046/j.1365-2249.2000.01167.x", "PMC1905591", "10691912"]}, {"Citation": "Kussainova A, et al. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS ONE. 2020;15:e0241445. doi: 10.1371/journal.pone.0241445.", "ArticleIdList": ["10.1371/journal.pone.0241445", "PMC7654800", "33170870"]}, {"Citation": "Liang L, Li Y, Tian X, Zhou J, Zhong L. Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo. Clinical and Experimental Dermatology. 2019;44:e216\u2013e223. doi: 10.1111/ced.13961.", "ArticleIdList": ["10.1111/ced.13961", "30859585"]}, {"Citation": "Liu W, et al. Urinary metabolomic investigations in vitiligo patients. Scientific Reports. 2020;10:1\u201311. doi: 10.1038/s41598-019-56847-4.", "ArticleIdList": ["10.1038/s41598-019-56847-4", "PMC7582886", "33093609"]}, {"Citation": "Malhotra AG, Jha M, Singh S, Pandey KM. Construction of a comprehensive protein\u2013protein interaction map for vitiligo disease to identify key regulatory elements: A systemic approach. Interdisciplinary Sciences: Computational Life Sciences. 2018;10:500\u2013514.", "ArticleIdList": ["28290051"]}, {"Citation": "Mori M. Regulation of nitric oxide synthesis and apoptosis by arginase and arginine recycling. The Journal of Nutrition. 2007;137:1616S\u20131620S. doi: 10.1093/jn/137.6.1616S.", "ArticleIdList": ["10.1093/jn/137.6.1616S", "17513437"]}, {"Citation": "Murakami H, Shimbo K, Inoue Y, Takino Y, Kobayashi H. Importance of amino acid composition to improve skin collagen protein synthesis rates in UV-irradiated mice. Amino Acids. 2012;42:2481\u20132489. doi: 10.1007/s00726-011-1059-z.", "ArticleIdList": ["10.1007/s00726-011-1059-z", "PMC3351609", "21861170"]}, {"Citation": "Newsholme P, Procopio J, Lima MMR, Pithon-Curi TC, Curi R. Glutamine and glutamate\u2014their central role in cell metabolism and function. Cell Biochemistry and Function. 2003;21:1\u20139. doi: 10.1002/cbf.1003.", "ArticleIdList": ["10.1002/cbf.1003", "12579515"]}, {"Citation": "Pekala J, et al. L-carnitine-metabolic functions and meaning in humans life. Current Drug Metabolism. 2011;12:667\u2013678. doi: 10.2174/138920011796504536.", "ArticleIdList": ["10.2174/138920011796504536", "21561431"]}, {"Citation": "Phang JM. Proline metabolism in cell regulation and cancer biology: Recent advances and hypotheses. Antioxidants & Redox Signaling. 2019;30:635\u2013649. doi: 10.1089/ars.2017.7350.", "ArticleIdList": ["10.1089/ars.2017.7350", "PMC6338564", "28990419"]}, {"Citation": "Rath M, M\u00fcller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Frontiers in Immunology. 2014;5:532. doi: 10.3389/fimmu.2014.00532.", "ArticleIdList": ["10.3389/fimmu.2014.00532", "PMC4209874", "25386178"]}, {"Citation": "Rodrigues, M., K. Ezzedine, I. Hamzavi, A. G. Pandya, J. E. Harris, V. W. Group New discoveries in the pathogenesis and classification of vitiligo. Journal of the American Academy of Dermatology. 2017;77:1\u201313. doi: 10.1016/j.jaad.2016.10.048.", "ArticleIdList": ["10.1016/j.jaad.2016.10.048", "28619550"]}, {"Citation": "Roy, S. (2007). Melanin, melanogenesis, and vitiligo Progress in the Chemistry of Organic Natural Products.(pp131\u2013185). Springer.", "ArticleIdList": ["17302180"]}, {"Citation": "Sabry HH, Sabry JH, Hashim HM. Serum levels of homocysteine, vitamin B12, and folic acid in vitiligo. Egyptian Journal of Dermatology and Venerology. 2014;34:65\u201369. doi: 10.4103/1110-6530.137315.", "ArticleIdList": ["10.4103/1110-6530.137315"]}, {"Citation": "Sahoo A, et al. MicroRNA-211 regulates oxidative phosphorylation and energy metabolism in human vitiligo. Journal of Investigative Dermatology. 2017;137:1965\u20131974. doi: 10.1016/j.jid.2017.04.025.", "ArticleIdList": ["10.1016/j.jid.2017.04.025", "PMC6233982", "28502800"]}, {"Citation": "Seneschal, J., K. Boniface, A. D\u2019Arino, M. Picardo (2020). An update on Vitiligo pathogenesis. Pigment cell & melanoma research,", "ArticleIdList": ["33278065"]}, {"Citation": "Shaker O, El-Tahlawi S. Is there a relationship between homocysteine and vitiligo? A pilot study. British Journal of Dermatology. 2008;159:720\u2013724.", "ArticleIdList": ["18616781"]}, {"Citation": "Simi\u0144ska E, Koba M. Amino acid profiling as a method of discovering biomarkers for early diagnosis of cancer. Amino Acids. 2016;48:1339\u20131345. doi: 10.1007/s00726-016-2215-2.", "ArticleIdList": ["10.1007/s00726-016-2215-2", "27033065"]}, {"Citation": "Singh RK, et al. The role of IL-17 in vitiligo: A review. Autoimmunity Reviews. 2016;15:397\u2013404. doi: 10.1016/j.autrev.2016.01.004.", "ArticleIdList": ["10.1016/j.autrev.2016.01.004", "PMC4769658", "26804758"]}, {"Citation": "Singh S, Singh U, Pandey SS. Increased level of serum homocysteine in vitiligo. Journal of Clinical Laboratory Analysis. 2011;25:110\u2013112. doi: 10.1002/jcla.20442.", "ArticleIdList": ["10.1002/jcla.20442", "PMC6647724", "21438003"]}, {"Citation": "Speeckaert R, Speeckaert M, De Schepper S, van Geel N. Biomarkers of disease activity in vitiligo: A systematic review. Autoimmunity Reviews. 2017;16:937\u2013945. doi: 10.1016/j.autrev.2017.07.005.", "ArticleIdList": ["10.1016/j.autrev.2017.07.005", "28698094"]}, {"Citation": "Spritz RA, Andersen GH. Genetics of vitiligo. Dermatologic Clinics. 2017;35:245\u2013255. doi: 10.1016/j.det.2016.11.013.", "ArticleIdList": ["10.1016/j.det.2016.11.013", "PMC5362127", "28317533"]}, {"Citation": "Ta\u00efeb A, Picardo M, o. V. members, The definition and assessment of vitiligo: A consensus report of the Vitiligo European Task Force. Pigment Cell Research. 2007;20:27\u201335. doi: 10.1111/j.1600-0749.2006.00355.x.", "ArticleIdList": ["10.1111/j.1600-0749.2006.00355.x", "17250545"]}, {"Citation": "Vernwal D. A study of anxiety and depression in Vitiligo patients: New challenges to treat. European Psychiatry. 2017;41:S321\u2013S321. doi: 10.1016/j.eurpsy.2017.02.242.", "ArticleIdList": ["10.1016/j.eurpsy.2017.02.242"]}, {"Citation": "Wu G, et al. Proline and hydroxyproline metabolism: Implications for animal and human nutrition. Amino Acids. 2011;40:1053\u20131063. doi: 10.1007/s00726-010-0715-z.", "ArticleIdList": ["10.1007/s00726-010-0715-z", "PMC3773366", "20697752"]}, {"Citation": "Wu G, Bazer FW, Hu J, Johnson GA, Spencer TE. Polyamine synthesis from proline in the developing porcine placenta. Biology of Reproduction. 2005;72:842\u2013850. doi: 10.1095/biolreprod.104.036293.", "ArticleIdList": ["10.1095/biolreprod.104.036293", "15576824"]}, {"Citation": "Wu J-L, Yu S-Y, Wu S-H, Bao A-M. A sensitive and practical RP-HPLC-FLD for determination of the low neuroactive amino acid levels in body fluids and its application in depression. Neuroscience Letters. 2016;616:32\u201337. doi: 10.1016/j.neulet.2016.01.024.", "ArticleIdList": ["10.1016/j.neulet.2016.01.024", "26808642"]}, {"Citation": "Zheleva A, Nikolova G, Karamalakova Y, Hristakieva E, Lavcheva R, Gadjeva V. Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy. Regulatory Toxicology and Pharmacology. 2018;94:234\u2013239. doi: 10.1016/j.yrtph.2018.02.008.", "ArticleIdList": ["10.1016/j.yrtph.2018.02.008", "29454011"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "29"}, {"Year": "2021", "Month": "9", "Day": "15"}, {"Year": "2021", "Month": "9", "Day": "25", "Hour": "12", "Minute": "8"}, {"Year": "2021", "Month": "9", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "25"}], "PublicationStatus": "epublish", "ArticleIdList": ["34562159", "PMC8464575", "10.1007/s11306-021-01843-x", "10.1007/s11306-021-01843-x"]}}], "PubmedBookArticle": []}